Ephraim S. Casper

Pancreatic Adenocarcinoma, Version 2.2014

Margaret A. Tempero, Mokenge P. Malafa, Stephen W. Behrman et al. · Journal of the National Comprehensive Cancer Network · 2014 · 463 citations

Surgical Oncology, Cancer Management, Nccn Guidelines Insights +16

Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas

Ephraim S. Casper, Mark R. Green, David P. Kelsen et al. · Investigational New Drugs · 1994 · 440 citations

Oncology, Phase Ii Trial, Pancreatic Cancer +5

Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face

Farid Fata, Eileen M. O’Reilly, David H. Ilson et al. · Cancer · 1999 · 387 citations · Full text

Desire for Information and Involvement in Treatment Decisions: Elderly Cancer Patients' Preferences and Their Physicians' Perceptions

Elena B. Elkin, Susie H.M. Kim, Ephraim S. Casper et al. · Journal of Clinical Oncology · 2007 · 371 citations · Full text

Cisplatin and Vindesine Combination Chemotherapy for Advanced Carcinoma of the Lung: A Randomized Trial Investigating Two Dosage Schedules

Richard J. Gralla, Ephraim S. Casper, David P. Kelsen et al. · Annals of Internal Medicine · 1981 · 366 citations

New Agents, Pharmacotherapy, Metronomic Chemotherapy +17